Recent advances in the molecular genetics of hypertension

Current Opinion in Nephrology and Hypertension

Volumn 5, Issue 2, 1996, Pages 162-165

  Shimkets, Richard A ^a   Lifton, Richard P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINERALOCORTICOID;

ESSENTIAL HYPERTENSION; HEREDITY; HUMAN; HYPERTENSION; LIDDLE SYNDROME; MOLECULAR GENETICS; MUTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; HUMANS; HYPERTENSION; MOLECULAR BIOLOGY;

EID: 0029943689     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199603000-00011     Document Type: Review

References (31)

1. Liddle GW, Bledsoe T, Coppage WS: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 1963, 76:199-213.
2. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson HH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW et al.: Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 1994, 79:407-418. Linkage analysis with Liddle's original kindred extended revealed highly significant linkage to the epithelial sodium channel β subunit. A premature stop codon in the carboxyl terminus of this channel gene was completely linked with the disease. Four additional Liddle's syndrome kindreds were shown to harbor non-sense or frameshift mutations in the carboxyl terminus of this channel subunit.
3. + channel is made of three homologous subunits. Nature 1994, 367:463-467.
4. Schild L, Canessa CM, Shimkets RA, Gautschi I, Lifton RP, Rossier BC: A mutation in the epithelial sodium channel causing Liddle's disease increases channel activity in Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA 1995, 92:56699-56703. Expression of epithelial sodium channels containing truncated β and γ subunits constitutively increased channel activity, explaining the pathogenesis of Liddle's syndrome.
5. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton R: Hypertension caused by a truncated epithelial sodium channel y subunit: genetic heterogeneity of Liddle's syndrome. Nature Genet 1995, 11:76-80. A patient with Liddle's syndrome and no mutation in the epithelial sodium channel β subunit was shown to have a premature stop codon in the nearby γ subunit, demonstrating genetic heterogeneity of Liddle's syndrome.
6. Hansson J, Schild L, Lu Y, Wilson T, Gautschi I, Shimkets R, Canessa C, Nelson-Williams C, Rossier B, Lifton R: A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle's syndrome and identifies a proline-rich segment of the protein critical for regulation of channel activity. Proc Natl Acad Sci USA 1995, 92:11495-11499. A de-novo point mutation in the β subunit of the epithelial sodium channel pinpoints a critical residue for normal negative regulation of channel activity.
7. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Hausman DE, Evans RM: Cloning of human mineralocorticoid receptor complimentary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987, 237:268-275.
8. New MI, Levine L, Biglieri E, Pariera J, Ulick S: Evidence for an unidentified steroid in a child with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1977, 44:924-933.
9. Oberfield SE, Levine LS, Carey RM, Grier F, Ulick S: Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1983, 56:332-339.
10. Ulick S, Levine LS, Gunczler P, Giovanni Z, Ramirez C, Rauh W, Rosler A, Bradlow KL, New MI: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979, 49:757-764.
11. Shackleton CHL, Honour JW, Dillon MJ, Chantier C, Jones RWA: Hypertension in a four-year-old child: gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J Clin Endocrinol Metab 1980, 50:786-792.
12. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS: Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type II enzyme. Mol Cell Endocrinol 1994, 105:11-17.
13. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC: Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genet 1995, 10:394-399. Nine patients with AME have been shown to bear deleterious mutations in that gene. Expression of these variants in Chinese hamster ovary cells demonstrated decreased enzymatic activity.
14. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI: A mutation in HSD11β2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995, 80:2263-2266. A patient with AME was shown to harbor a mutation in the kidney 11β-hydroxysteroid dehydrogenase gene.
15. Kornel L, Starnes WR, Hill SR Jr, Hill A: Studies on steroid conjugates: IV. Quantitative paper chromatography of urinary corticosteroids in essential hypertension. J Clin Endocrinol 1969, 29:1608-1617.
16. Soro A, Ingram MC, Tonolo G, Glorioso N, Frasier R: Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension. Hypertension 1995, 25:67-70.
17. Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW: Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogens in essential hypertension. Clin Endocrinol 1993, 39:221-227.
18. Shackleton CHL, Rodriguez J, Arteaga E, Lopez JM, Winter JSD: Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol 1985, 22:701-712.
19. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton RP, Williams C, Charru A, Hunt S, Hopkins PN, Williams RR, Lalouel JM, Corvol P: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
20. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotemihen B, Ward R: Angiotensinogen gene in human hypertension. Lack of association of the 235T allele among African Americans. Hypertension 1994, 25:591-594.
21. Inoue I, Rohrwasser A, Helin C, Jeunemaitre X, Crain P, Bohlender J, Lifton RP, Corvol P, Ward K, Lalouel JM: A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem 1995, 270:11430-11436. A new variant was discovered in the angiotensinogen gene in a preeclamptic patient; this variant alters the site cleaved by renin and apparently alters the kinetics of the renin-angiotensin system.
22. Nabika T, Bonnardeaux A, James M, Julier C, Jeunemaitre X, Corvol P, Lathrop M, Soubrier F: Evaluation of the SA locus in human hypertension. Hypertension 1995, 25:6-13.
23. Samani NJ, Whitmore SA, Kaiser MA, Harris J, See CG, Callen DF, Lodwick D: Chromosomal assignment of the human SA gene to 16p13.11 and demonstration of its expression in the kidney. Biochem Biophys Res Commun 1994, 199:862-868.
24. Iwai N, Ohmichi N, Hanai K, Nakamura Y, Kinoshita M: Human SA gene locus as a candidate locus for essential hypertension. Hypertension 1994, 23:375-380.
25. Bonnardeuax A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F: Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 1995, 91:96-102.
26. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F et al.: Association of the alpha-adducin locus with essential hypertension. Hypertension 1995, 25:320-326.
27. Jacob HJ, Brown DM, Bunker RK, Daly MJ, Dzau VJ, Goodman A, Koike G, Kren V, Kurtz T, Lernmark A et al.: A genetic linkage map of the laboratory rat Rattus Norvegicus. Nature Genet 1995, 9:63-69. A genetic map for the laboratory rat, providing tools for mapping trait loci in this commonly used experimental animal.
28. Deng AY, Rapp JP: Locus for the inducible, but not constitutive, nitric oxide synthase cosegregates with blood pressure in the Dahl salt-sensitive rat. J Clin Invest 1995, 95:2170-2177. The genes for two isoforms of NOS were tested for linkage with blood pressure in the Dahl salt-sensitive rat. The inducible enzyme, NOS II, showed evidence for linkage with blood pressure levels.
29. Schork NJ, Kreiger JE, Trolliet MR, Franchini KG, Koike G, Kreiger EM, Lander ES, Dzau VJ, Jacob HJ: A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res 1995, 5:164-172. A genome-wide search for loci contributing to blood pressure in the spontaneously hypertensive rat has revealed six genomic loci contributing in an additive manner to 43% of the variation of blood pressure in these rats.
30. Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995, 92:2735-2739. The modulation of copy number of native angiotensinogen genes in rats has revealed an almost linear contribution of gene copy number with angiotensinogen levels and blood pressure.
31. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 1995, 92:3521-3525.